George A. Scangos, Director of Voyager Therapeutics VYGR, has filed 0 purchases and 12 sales on the open market. The latest trade was on 06/09.

GS

GS

George A. Scangos

Director

Company

Voyager Therapeutics VYGR

First filing

23/02/21

Trades

47 trades

Buys / sales

0 / 12

12-month net buying

No record

Last trade

06/09

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Vir BiotechnologyVIR	Open-market sale10b5-1 plan	25/02/24	25/02/25	10,056 sh	$9.45	$95,029.2	−1.4%
Vir BiotechnologyVIR	Open-market sale10b5-1 plan	25/02/18	25/02/19	10,964 sh	$9.81	$107,556.84	−1.5%
Vir BiotechnologyVIR	Open-market sale10b5-1 plan	24/02/22–24/02/26	24/02/26	27,750 sh2 trades	$11.07avg.	$307,242.7	−19.7%
Vir BiotechnologyVIR	Open-market sale10b5-1 plan	24/02/16–24/02/20	24/02/20	27,750 sh2 trades	$10.23avg.	$283,822.56	−16.5%
Vir BiotechnologyVIR	Open-market sale	23/02/23–23/02/24	23/02/24	27,750 sh3 trades	$24.53avg.	$680,754.73	−14.1%
Vir BiotechnologyVIR	Open-market sale	23/02/17–23/02/21	23/02/21	27,750 sh3 trades	$27.23avg.	$755,594.1	−12.4%